Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Rockledge. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Rockledge at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
The main objectives of the study are to demonstrate pharmacokinetics (PK) similarity between ABP 692 and Ocrelizumab (US), and ABP 692 and Ocrelizumab (EU), and to demonstrate pharmacodynamics (PD) similarity between ABP 692 and Ocrelizumab reference product (RP) based on assessment of the suppression of new active brain lesions over 24 weeks as assessed by magnetic brain imaging (MRI).
Sponsor: Amgen
Check if you qualify for this multiple sclerosis clinical trial in Rockledge, FL
If you're searching for multiple sclerosis treatment options in Rockledge, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rockledge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.